{"id":7206,"date":"2016-08-14T03:26:59","date_gmt":"2014-08-14T03:26:59","guid":{"rendered":"http:\/\/www.edrugstore.md\/blog\/?p=7206"},"modified":"2014-08-15T18:35:27","modified_gmt":"2014-08-15T18:35:27","slug":"pfizer-beats-analyst-estimates-in-second-quarter","status":"publish","type":"post","link":"https:\/\/www.edrugstore.com\/blog\/erectile-dysfunction\/viagra\/pfizer-beats-analyst-estimates-in-second-quarter\/","title":{"rendered":"Pfizer Beats Analyst Estimates in Second Quarter"},"content":{"rendered":"
\"Mature
Pfizer products are much more than just Viagra.<\/figcaption><\/figure>\n

There\u2019s more to Pfizer than Viagra, and the second quarter figures appear to be evidence of that fact. The losses were great, there\u2019s no denying it. Earnings were down 79 percent over a year ago. What\u2019s surprising is that Pfizer performed better than anyone expected.<\/p>\n

ABC News<\/a>\u00a0says Pfizer came in just slightly over the mark. Where analysts predicted an adjusted earnings at 57 cents per share, the pharmaceutical giant came in at 58 cents. That\u2019s down from $1.98 last year.<\/p>\n

But every penny counts, especially when you\u2019re as large as Pfizer.<\/p>\n

The company doesn\u2019t appear to be disappointed, but rather encouraged by the one cent -per-share improvement over predicted earnings. In fact, the company has big plans for expansion, and is keeping its eye toward the future.<\/p>\n

Pfizer Has a Wide Range of Drugs Besides Viagra <\/strong><\/p>\n

Many prescription medications have patent protection, but they don\u2019t last forever. With a patent, another pharmaceutical company can\u2019t duplicate the formula, create a copy, and sell it at a reduced price as a generic or another brand.<\/p>\n

Pfizer\u2019s patents on Viagra are expiring around the world. With Viagra making up such a large portion of the company\u2019s earnings, the most logical predicted outcome was widespread losses. But that\u2019s not entirely what happened.<\/p>\n

Viagra isn\u2019t the only drug that Pfizer owns; they have other drugs on the market, and many of the names might sound familiar to you.<\/p>\n

Lyrica, for example, is a leading pain medication. Aricept is used as a treatment for Alzheimer\u2019s patients. Pfizer<\/a> \u00a0even owns the very familiar over-the-counter tooth pain drug, Anbesol.<\/p>\n

There is no shortage of earnings potential or this pharmaceutical company. But Viagra had once been an enormous seller, and that\u2019s slowing down. The sharp decline in earnings from one year to the next didn\u2019t surprise anyone, but Pfizer\u2019s other products help offset some of it.<\/p>\n

Lyrica and Other Drugs Steady the Company\u2019s Losses on Viagra <\/strong><\/p>\n

\"businessman,
Men know and trust the Viagra brand.<\/figcaption><\/figure>\n

Of the many Pfizer drugs on the market, Lyrica can take credit for making great strides in mitigating some of the losses from slowing Viagra sales.<\/p>\n

Laura Lorenzetti explains in her Forbes article, \u201cPfizer Beats Estimates as Viagra Loses Patent Protections<\/a>\u201d \u00a0that Lyrica sales have increased by 16 percent, bringing its earnings to $1.32 billion.<\/p>\n

And that\u2019s not the only drug doing well; Prevnar, which is a vaccine that protects against pneumonia, is up 13%, bringing its total earnings to $969 million. Lipitor is another in the stable. ABC says for more than 10 years, Lipitor was the best selling drug in the world, although it no longer holds that position.<\/p>\n

The list of Pfizer drugs is enormous. Some of them are well known and widely used. Others aren\u2019t, but together they are keeping Pfizer in the game.<\/p>\n

Pfizer Has Other, Bigger Plans <\/strong><\/p>\n

Pfizer had plans to buy the UK-based pharmaceutical company, AstraZeneca. But ABC reports that the UK company turned down the buyout proposal of nearly $120 billion in May of 2014. That would have been larger than any other pharmaceutical deal in history.<\/p>\n

Pfizer wants to branch out, and is keeping its options open. The company is considering deals that will help boost its new and experimental drug portfolio, says ABC, and those that would help reduce its tax burden.<\/p>\n

The AstraZeneca deal would have been a boon, tax-wise. Pfizer had intended to relocate its company legal headquarters to the UK, which would have dramatically reduced its taxes.<\/p>\n

\"couple
Men and women of all ages have benefitted from Pfizer products.<\/figcaption><\/figure>\n

In the U.S., the corporate tax structure costs Pfizer 35 percent. This doesn\u2019t just include profits from U.S. sales, but also sales in every other country. That\u2019s one reason why the company has such interest in corporate tax reform in the U.S.<\/p>\n

Staying in business means making smart financial moves. Although shifting headquarters to another country might not be a popular decision with everyone, American corporations, especially those with global sales, feel the tax sting.<\/p>\n

Lorenzetti says Pfizer and AstraZeneca aren\u2019t closing off communications about a deal. The UK company could reopen talks about a deal any time it likes. But for Pfizer to initiate the conversation, it has to wait until November, when Lorenzetti says the UK mandatory waiting period is over.<\/p>\n

Losing the Viagra patent did hurt Pfizer\u2019s earnings. Sales outside the U.S. dropped nearly 30 percent, and the company\u2019s other drugs haven\u2019t managed to make up the difference.<\/p>\n

But Ian Read, Pfizer\u2019s CEO, told Fortune that he\u2019s happy with the company\u2019s operating performance. He went on to say, \u201cOur recently launched products continued to gain traction during the quarter while our mid- and late-stage pipeline continued to progress.\u201d<\/p>\n

The AstraZeneca deal might be dead in the water, or it might only be on pause. But either way, Pfizer has lofty goals. It wants to become the largest pharmaceutical company in the world. Keeping its options open means anything could happen in the future.<\/p>\n

Viagra is alive and well at eDrugstore.com<\/a>. As one of the most widely recognizable brands of erection health medications, men throughout the US and the world know and trust the Little Blue Pill. We offer privacy and convenience of online shopping, and your discreetly-packed shipment arrives right at your door. If you\u2019re ready to try something that works, see what eDrugstore.com has to offer.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

There\u2019s more to Pfizer than Viagra, and the second quarter figures appear to be evidence of that fact. The losses were great, there\u2019s no denying it. Earnings were down 79 percent over a year ago. What\u2019s surprising is that Pfizer performed better than anyone expected. ABC News\u00a0says Pfizer came in just slightly over the mark. […]<\/p>\n","protected":false},"author":1,"featured_media":7225,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_autoblog_aioseo_focus_keyphrase":"","_autoblog_aioseo_title":"","_autoblog_aioseo_description":"","footnotes":""},"categories":[17],"tags":[],"class_list":["post-7206","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-viagra"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t